NPPA and atrial fibrillation: Immature iPSC-aCMs did not exhibit differences in ion channel expression when compared to NPPA-WT or the NPPA-S64R cell lines and therefore demonstrated only marginal reduction in the APD, thus making it impossible to uncover the AF mechanism or develop therapies targeting the EP substrate in patients carrying this mutation.